Watch About Donate Blog

David Sinclair

Professor of Genetics, Harvard Medical School; Professor, University of New South Wales
David A. Sinclair, Ph.D. is a tenured professor of Genetics at Harvard Medical School and a professor at the University of New South Wales. He is co-director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard. He is known for his work on understanding why we age and how to slow its effects, including co-discovering that the red wine molecule resveratrol can slow aspects of aging. He has founded a number of biotechnology companies in areas of aging, diabetes, vaccines and bioinformatics. He co-founded and serves as co-chief editor of the scientific journal Aging and is a regular guest and contributor to media and his work is featured in four books and two documentary movies. Sinclair has received awards including the Australian Commonwealth Prize, the Thompson Prize, a Helen Hay Whitney Postdoctoral Award, A Charles Hood Fellowship, a Leukemia Society Fellowship, a Ludwig Scholarship, a Harvard-Armenise Fellowship, an American Association for Aging Research Fellowship, The Nathan Shock Award from the National Institutes of Health, Ellison Medical Foundation Junior and Senior Scholar Awards, The Merck Prize, a Genzyme Outstanding Achievement in Biomedical Science Award, the Bio-Innovator Award, the David Murdock-Dole Lectureship, the Fisher Honorary Lectureship at UCLA, the Les Lazarus Lectureship, the ASMR Medal and TIME 100, a list of most influential people in the world.